Viewing Study NCT02673333


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-01-01 @ 12:22 AM
Study NCT ID: NCT02673333
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-20
First Post: 2016-02-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: